Track the 엔바이오니아 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Industrials sector, 엔바이오니아 has recorded 53 public disclosures. Market capitalisation: €34.4bn. The latest transaction was filed on 7 May 2026 (Sale). Among the most active insiders: 한정철. The full history is openly available.
53
Insider Decl.
n/a
Thresholds
n/a
4 ops.
Buy Volume
n/a
33 ops.
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,566 of 28,985 companies
8.4
score / 100
Value
7
Quality
9
FCF yld-47%
Earn yld-20%
EV/EBITDA·
ROE-25%
Gross mgn13%
Net mgn-65%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.